Skip to main content
Article

Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children

Lael M. YonkerHarvard Medical School, Boston, Massachusetts, USAJulie BoucauRagon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USAJames ReganBrigham and Women’s Hospital, Department of Medicine, Boston, Massachusetts, USAManish C. ChoudharyBrigham and Women’s Hospital, Department of Medicine, Boston, Massachusetts, USAMadeleine D. BurnsMassachusetts General Hospital, Mucosal Immunology and Biology Research Center, Boston, Massachusetts, USANicola YoungMassachusetts General Hospital, Mucosal Immunology and Biology Research Center, Boston, Massachusetts, USAE FarkasMassachusetts General Hospital, Mucosal Immunology and Biology Research Center, Boston, Massachusetts, USAJameson P. DavisMassachusetts General Hospital, Mucosal Immunology and Biology Research Center, Boston, Massachusetts, USAPeter P. MoschovisHarvard Medical School, Boston, Massachusetts, USAT. Bernard KinaneHarvard Medical School, Boston, Massachusetts, USAAlessio FasanoHarvard Medical School, Boston, Massachusetts, USAAnne M. NeilanHarvard Medical School, Boston, Massachusetts, USAJonathan Z. LiBrigham and Women’s Hospital, Department of Medicine, Boston, Massachusetts, USAAmy K. BarczakHarvard Medical School, Boston, Massachusetts, USA
2021en
ABI

Abstract

BACKGROUND: Data on pediatric coronavirus disease 2019 (COVID-19) has lagged behind adults throughout the pandemic. An understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral dynamics in children would enable data-driven public health guidance. METHODS: Respiratory swabs were collected from children with COVID-19. Viral load was quantified by reverse-transcription polymerase chain reaction (RT-PCR); viral culture was assessed by direct observation of cytopathic effects and semiquantitative viral titers. Correlations with age, symptom duration, and disease severity were analyzed. SARS-CoV-2 whole genome sequences were compared with contemporaneous sequences. RESULTS: One hundred ten children with COVID-19 (median age, 10 years [range, 2 weeks-21 years]) were included in this study. Age did not impact SARS-CoV-2 viral load. Children were most infectious within the first 5 days of illness, and severe disease did not correlate with increased viral loads. Pediatric SARS-CoV-2 sequences were representative of those in the community and novel variants were identified. CONCLUSIONS: Symptomatic and asymptomatic children can carry high quantities of live, replicating SARS-CoV-2, creating a potential reservoir for transmission and evolution of genetic variants. As guidance around social distancing and masking evolves following vaccine uptake in older populations, a clear understanding of SARS-CoV-2 infection dynamics in children is critical for rational development of public health policies and vaccination strategies to mitigate the impact of COVID-19.

Identifiers

Citations and references

Cited by 20 references